Summary
Paul Danese is a biotech-focused software founder and scientist who blends bench biology with data-driven regulatory analysis. As Co-Founder of FDAble LLC since 2009, he focuses on adverse-event database search and analysis, with emphasis on FDA MAUDE and FAERS/AERS data to derive safety insights. His career spans senior scientific roles at Rib-X Pharmaceuticals and Microbia (Ironwood), and a Harvard postdoctoral fellow, supported by a Ph.D. and an M.A. in Molecular Biology from Princeton. He earned a B.S. in Biochemistry from the University of Massachusetts Amherst, grounding his work in strong foundational science. Based in Glastonbury, CT, he combines research rigor with practical software-enabled data analysis to empower safer, evidence-driven decisions in healthcare regulatory spaces.
11 years of coding experience
8 years of employment as a software developer
B.S., Biochemistry, B.S., Biochemistry at University of Massachusetts Amherst
Pittsfield High School
Ph.D., Molecular Biology, Ph.D., Molecular Biology at Princeton University